News from us and our partners

Tags

Topics

0 results

News
30 August, 2022
Sofinnova's Henrijette Richter talks to BioCentury about creating support networks for first-time CEOs
News
22 August, 2022
Pi-Cardia successfully performs mitral valve splitting with ShortCut(TM)
News
10 August, 2022
Nephris welcomes discovery of novel pathogenic factor in diabetic kidney disease
News
8 August, 2022
CinCor Pharma announces positive topline data for Phase 2 BrigHtn trial evaluating baxdrostat, its selective aldosterone synthase inhibitor, in treatment-resistant hypertension
News
4 August, 2022
F2G announces $70 million financing to advance development and commercialization of new antifungal agent olorofim
News
4 August, 2022
Noema Pharma announces recruitment of first patient in Orpheus Phase 2b Study of PDE10A inhibitor gemlapodect in adults with childhood onset fluency disorder
News
26 July, 2022
CinCor Pharma announces last patient randomized in Phase 2 HALO Trial and initiation of long-term extension study for Baxdrostat, a selective aldosterone synthase inhibitor, in uncontrolled hypertension
News
26 July, 2022
ReCor Medical and Otsuka Medical Devices announce primary endpoint met in the RADIANCE II U.S. pivotal trial of the Paradise™ System for the treatment of hypertension
News
26 July, 2022
Pixium Vision announces successful implantation of first patient in the Netherlands in Prima System European pivotal trial PRIMAvera
News
26 July, 2022
Pi-Cardia receives FDA IDE approval for pivotal study with ShortCut(TM) device
News
15 July, 2022
Dr. Neal Gutterson joins Meiogenix board of directors
News
12 July, 2022
Tissium appoints Maria Sainz as Independent Board Member
News
12 July, 2022
GlycoEra AG expands Board of Directors and appoints Georges Gemayel, Ph.D., as Chair
News
12 July, 2022
Micropep raises €8.75M Series A1 for micropeptide crop protection
News
11 July, 2022
SafeHeal appoints medical device industry veteran Chris Richardson as Chief Executive Officer
News
11 July, 2022
Inspirna raises $50 million in Series D financing

Sofinnova's Henrijette Richter talks to BioCentury about creating support networks for first-time CEOs

Pi-Cardia successfully performs mitral valve splitting with ShortCut(TM)

Nephris welcomes discovery of novel pathogenic factor in diabetic kidney disease

CinCor Pharma announces positive topline data for Phase 2 BrigHtn trial evaluating baxdrostat, its selective aldosterone synthase inhibitor, in treatment-resistant hypertension

F2G announces $70 million financing to advance development and commercialization of new antifungal agent olorofim

Noema Pharma announces recruitment of first patient in Orpheus Phase 2b Study of PDE10A inhibitor gemlapodect in adults with childhood onset fluency disorder

CinCor Pharma announces last patient randomized in Phase 2 HALO Trial and initiation of long-term extension study for Baxdrostat, a selective aldosterone synthase inhibitor, in uncontrolled hypertension

ReCor Medical and Otsuka Medical Devices announce primary endpoint met in the RADIANCE II U.S. pivotal trial of the Paradise™ System for the treatment of hypertension

Pixium Vision announces successful implantation of first patient in the Netherlands in Prima System European pivotal trial PRIMAvera

Pi-Cardia receives FDA IDE approval for pivotal study with ShortCut(TM) device

Dr. Neal Gutterson joins Meiogenix board of directors

Tissium appoints Maria Sainz as Independent Board Member

GlycoEra AG expands Board of Directors and appoints Georges Gemayel, Ph.D., as Chair

Micropep raises €8.75M Series A1 for micropeptide crop protection

SafeHeal appoints medical device industry veteran Chris Richardson as Chief Executive Officer

Inspirna raises $50 million in Series D financing